论文部分内容阅读
在2008年版的世界卫生组织(WHO)造血和淋巴组织肿瘤分类中,老年人EB病毒(EBV)阳性弥漫性大B细胞淋巴瘤(DLBCL)作为新的类型被单独列出〔1〕。老年人EBV阳性DLBCL有与DLBCL其他亚型不同的形态学及生物学特征,临床过程呈高度侵袭性,常规化疗效果差,总生存期短〔2-4〕。老年人EBV阳性DLBCL发病率相对较低,国内研究较少,国外报道也不多。如何提高患
Elderly EBV-positive diffuse large B-cell lymphoma (DLBCL) is listed as a new type in the 2008 WHO classification of hematopoietic and lymphoid tumors [1]. Elderly EBV-positive DLBCL and DLBCL have other subtypes of different morphological and biological characteristics, the clinical course was highly invasive, conventional chemotherapy, poor overall survival [2-4]. The incidence of EBV-positive DLBCL in the elderly is relatively low, with few studies in China and not many foreign reports. How to improve the suffering